Stress-induced apoptosis and the sphingomyelin pathway

Biochemical Pharmacology

Volumn 53, Issue 5, 1997, Pages 615-621

  Peña, Louis A ^a   Fuks, Zvi ^a   Kolesnick, Richard ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

apoptosis; ceramide; cytokines; environmental stress; ICE proteases; sphingomyelin; sphingomyelinase

Indexed keywords

CERAMIDE; ESTERASE; PROTEIN KINASE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ENZYME ACTIVITY; HUMAN; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS;

EID: 0038985463     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00834-9     Document Type: Note

References (63)

1. Fisher DE, Apoptosis in cancer therapy: Crossing the threshold. Cell 78: 539-542, 1994.
2. Thompson C, Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
3. Martin SJ and Green DR, Protease activation during apoptosis: Death by a thousand cuts? Cell 82: 349-352, 1995.
4. Patel T, Gores GJ and Kaufman SH, The role of proteases during apoptosis. FASEB J 10: 587-597, 1996.
5. Miura M, Zhu H, Rotello R, Hartwieg EA and Yuan J, Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660, 1993.
6. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC, Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994.
7. Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM, FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512, 1995.
8. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and Dixit VM. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271: 4961-4965, 1996.
9. Enari M, Talanian RV, Wong WW and Nagata S, Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723-726, 1996.
10. Hannun Y, The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269: 3125-3128, 1994.
11. Kolesnick R and Golde DW, The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328, 1994.
12. Hannun YA and Obeid LM, Ceramide: An intracellular signal for apoptosis. Trends Biochem Sci 20: 73-77, 1995.
13. Jarvis WD, Grant S and Kolesnick RN, Ceramide and the induction of apoptosis. Clin Cancer Res 2: 1-6, 1996.
14. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z and Kolesnick R, Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82: 405-414, 1995.
15. 3 in HL-60 cells: Role in cell differentiation. J Biol Chem 264: 19076-19080, 1989.
16. Olivera A, Buckley NE and Spiegel S, Sphingomyelinase and cells permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J Biol Chem 267: 26121-26127, 1992.
17. Boucher L-M, Weigmann K, Futterer A, Pfeffer K, Machleidt T, Schütze S, Mak TW and Krönke M, CD28 signals through acidic sphingomyelinase. J Exp Med 181: 2059-2068, 1995.
18. Kolesnick R and Fuks Z, Ceramide: A signal for apoptosis or mitogenesis? J Exp Med 181: 1949-1952, 1995.
19. Yanaga F and Watson SP, Tumor necrosis factor α stimulates sphingomyelinase through the 55 kDa receptor in HL-60 cells. FEBS Lett 314: 297-300, 1992.
20. Dressler KA, Mathias S and Kolesnick RN, Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255: 1715-1718, 1992.
21. Wiegmann K, Schütze S, Machleidt T, Witte D and Krönke M, Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015, 1994.
22. Wright SC, Zheng H and Zhong J, Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J 10: 325-332, 1996.
23. 2 production and sphingomyelin metabolism. J Biol Chem 267: 20044-20050, 1992.
24. Mathias S, Younes A, Kan C-C, Orlow I, Joseph C and Kolesnick RN, Activation of the sphingomyelin pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259: 519-522, 1993.
25. Dobrowsky RT, Werner MH, Castellino AM, Chao MV and Hannun YA, Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 265: 1596-1599, 1994.
26. NTR with Trk receptors. J Biol Chem 270: 22135-22142, 1995.
27. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A and Testi R, Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180: 1547-1552, 1994.
28. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G and Testi R, Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. Embo J 14: 5859-5868, 1995.
29. Haimovitz-Friedman A, Kan C-C, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z and Kolesnick RN, Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180: 525-535, 1994.
30. Chang Y, Abe A and Shayman JA, Ceramide formation during heat shock: A potential mediator of αB-crystallin transcription. Proc Natl Acad Sci USA 92: 12275-12279, 1995.
31. Martin SJ, Newmeyer DD, Mathias S, Farschon DM, Wang HG, Reed JC, Kolesnick RN and Green DR, Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J 14: 5191-5200, 1995.
32. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MH, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN, Requirement of ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75-79, 1996.
33. Zhang J, Alter N, Reed JC, Borner C, Obeid LM and Hannun YA, Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93: 5325-5328, 1996.
34. Kolesnick RN, Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30: 1-38, 1991.
35. Horinouchi K, Erlich S, Perl D, Ferlinz K, Bisgaier CL, Sandhoff K, Desnick RJ, Stewart CL and Schuchman EH, Acid sphingomyelinase deficient mice: A model of types A and B Niemann-Pick disease. Nat Genet 10: 288-293, 1995.
36. Otterbach B and Stoffel W, Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81: 1053-1061, 1995.
37. Adam D, Wiegmann K, Adam-Klages S, Ruff A and Krönke M, A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J Biol Chem 271: 14617-14622, 1996.
38. Schütze S, Potthoff K, Machleidt T, Wiegman K and Krönke M, TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71: 765-776, 1992.
39. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kolanus W, Schneider-Mergener J and Krönke M, FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86: 937-947, 1996.
40. Feinstein E, Kimchi A, Wallach D, Boldin M and Varfolomeev E, The death domain: A module shared by proteins with diverse cellular functions. Trends Biochem Sci 20: 342-344, 1995.
41. Schuchman EH and Desnick RJ, Niemann-Pick disease types A and B: Acid sphingomyelinase deficiencies. In: The Metabolic and Molecular Basis of Inherited Disease (Eds. Scriver CR, Beaudet AL, Sly WS and Valle D), 7th Edn, Vol. II, pp. 2601-2624. McGraw-Hill, New York, 1995.
42. Santana P, Peña LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z and Kolesnick R, Acid sphingomyelinase deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86: 189-199, 1996.
43. Mathias S, Dressler KA and Kolesnick RN, Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor-α. Proc Natl Acad Sci USA 88: 10009-10013, 1991.
44. Joseph CK, Byun H-S, Bittman R and Kolesnick RN, Substrate recognition by ceramide-activated protein kinase: Evidence that kinase activity is proline-directed. J Biol Chem 268: 20002-20006, 1993.
45. Yao B, Zhang Y, Delikat S, Mathias S, Basu S and Kolesnick R, Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307-310, 1995.
46. Dobrowsky RT, Kamibayashi C, Mumby MC and Hannun YA, Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268: 15523-15530, 1993.
47. 1 arrest of Saccharomyces cerevisiae. Genes Dev 10: 382-394, 1996.
48. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L and Moscat J, Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem 269: 19200-19202, 1994.
49. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D and Pfizenmaier K, PKCζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14: 1961-1969, 1995.
50. Gulbins E, Coggeshall KM, Baier G, Telford D, Langlet C, Baier-Bitterlich G, Bonnefoy-Berard N, Burn P, Wittinghofer A and Altman A, Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol 14: 4749-4758, 1994.
51. Kyriakis J, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad M, Avurch J and Woodgett J, The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160, 1994.
52. Kyriakis JM, Woodett JR and Avruch J, The stress-activated protein kinases. A novel ERK subfamily responsive to cellular stress and inflammatory cytokines. Ann NY Acad Sci 766: 303-319, 1995.
53. Cano E and Maadevan LC, Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20: 117-122, 1995.
54. 1 Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem J 316: 13-17, 1996.
55. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS and Spiegel S, Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803, 1996.
56. Pyne S, Chapman J, Steele L and Pyne NJ, Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur J Biochem 237: 819-826, 1996.
57. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA and Brenner DA, Ceramide activates the stress-activated protein kinases. J Biol Chem 270: 22689-22692, 1995.
58. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME, Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995.
59. Smyth MJ, Perry DK, Zang J, Poirier GG, Hannun YA and Obeid LM, prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem J 316: 25-28, 1996.
60. Hsu H, Xiong J and Goeddel DB, The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81: 495-504, 1995.
61. Pronk GJ, Ramer K, Amiri P and Williams LT, Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271: 808-810, 1995.
62. Cheng A and Caffrey M, Free radical mediated X-ray damage of model membranes. Biophys J 70: 2212-2222, 1996.
63. Devary Y, Gottlieb RA, Smeal T and Karin M, The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081-1091, 1992.